Endeavor Health joins multi-institution Chicago Breast Cancer Research Consortium
Endeavor Health joins multi-institution Chicago Breast Cancer Research Consortium CBS News
411 материалов по теме, собраны автоматически из проверенных источников
Endeavor Health joins multi-institution Chicago Breast Cancer Research Consortium CBS News
Treating individual metastatic tumors with highly focused radiation or surgery did not improve progression-free or overall survival for patients with oligometastatic breast cancer receiving first-line systemic therapy, according to results from the randomized NRG-BR002 clinical trial led by researchers at The…
Breathe BioMedical Expands Multi-Center Clinical Study in Breast Cancer to Nova Scotia Yahoo Finance
Tukysa Wins FDA Nod for First-Line HER2-Positive Breast Cancer Maintenance After Trial Showed 8.6-Month Longer Median Disease Control Medical Daily
Study challenges treatment approach for rare triple-negative breast cancer FemTech World
Breast cancer study uncovers potential new Achilles’ heel for cancer cells The Institute of Cancer Research
Как агрессивный рак груди проникает в мозг: исследование Наука Mail
Right-sizing treatment for HER2-positive breast cancer: evolving algorithms across the disease continuum Nature
Breast cancer can behave differently in older women. This physician is making more tailored treatments a reality STAT
Six ways U of A researchers are leading the way to better breast cancer treatment University of Alberta
В Восточном Казахстане рак молочной железы на I стадии регистрируют у 58% женщин Устинка
Randomized trial finds targeting individual metastases in oligometastatic breast cancer does not improve survival UT MD Anderson
The FDA has approved tucatinib plus trastuzumab and pertuzumab as front-line maintenance therapy for adults with unresectable, locally advanced or metastatic HER2-positive breast cancer following induction treatment. Tucatinib (Tukysa, Seagen), an oral tyrosine kinase inhibitor, had previously been approved in 2020 as…
Montefiore joins national study testing early-stage breast cancer treatment without surgery Bronx Times
Randomized trial finds targeting individual metastases in oligometastatic breast cancer does not improve survival | Newswise Newswise